Cardiac ischaemic stress: Cardiomyocyte Ca 2+, sex and sex steroids

Clinical and Experimental Pharmacology and Physiology

Volumn 38, Issue 10, 2011, Pages 717-723

  Bell, James R ^a   Mellor, Kimberley M ^a   Wollermann, Amanda C ^a   Delbridge, Lea Md ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Ca 2+; Ca 2+ calmodulin dependent kinase II; Ischaemia; Oestrogen; Testosterone

Indexed keywords

1,3,5 TRIS(4 HYDROXYPHENYL) 4 PROPYLPYRAZOLE; ANDROSTANOLONE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II DELTA B ISOFORM; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II DELTA C ISOFORM; CALCIUM CHANNEL L TYPE; CALCIUM ION; DIARYLPROPIONITRILE; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; G PROTEIN COUPLED RECEPTOR 30; HEAT SHOCK PROTEIN 70; HEAT SHOCK TRANSCRIPTION FACTOR 1; ISOENZYME; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLAMBAN; PROTEIN KINASE B; PROTON; SODIUM ION; TESTOSTERONE; UNCLASSIFIED DRUG;

ANAEROBIC GLYCOLYSIS; APOPTOSIS; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL NUCLEUS; CELL PH; CELLULAR DISTRIBUTION; CONFERENCE PAPER; CORONARY ARTERY BLOOD FLOW; CYTOSOL; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HEART FIBRILLATION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART STRESS; HEART VENTRICLE TACHYCARDIA; INOTROPISM; INTRACELLULAR SIGNALING; MYOCARDIAL DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTON SODIUM EXCHANGE; PROTON TRANSPORT; REPERFUSION INJURY; SARCOPLASMIC RETICULUM; SEX DIFFERENCE; SODIUM CALCIUM EXCHANGE; SODIUM CELL LEVEL; SODIUM TRANSPORT; UPREGULATION;

CALCIUM; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CARDIOTONIC AGENTS; FEMALE; GONADAL STEROID HORMONES; HUMANS; MALE; MODELS, CARDIOVASCULAR; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; SEX CHARACTERISTICS;

EID: 80053168420     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2011.05567.x     Document Type: Conference Paper

References (86)

1. Mendelsohn ME, Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science 2005; 308: 1583-7.
2. Hearse DJ. Myocardial ischaemia. Can we agree on a definition for the 21st century? Cardiovasc. Res. 1994; 28: 1737-44.
3. Yan GX, Kleber AG. Changes in extracellular and intracellular pH in ischemic rabbit papillary muscle. Circ. Res. 1992; 71: 460-70.
4. 23Na NMR study. J. Mol. Cell. Cardiol. 1991; 23: 297-307.
5. +] in ventricular myocytes. Am. J. Physiol. 1999; 277: H1817-22.
6. 23Na-NMR measurements of intracellular sodium in intact perfused ferret hearts during ischemia and reperfusion. Am. J. Physiol. 1990; 259: H1767-73.
7. 2+ exchange. Circ. Res. 1989; 65: 1045-56.
8. 31P-NMR study. J. Mol. Cell. Cardiol. 1993; 25: 1403-11.
9. + during myocardial ischemia: Consequences for post-ischemic recovery. J. Mol. Cell. Cardiol. 1997; 29: 85-96.
10. + exchanger are immediately active upon post-ischemic reperfusion in isolated rat hearts. J. Mol. Cell. Cardiol. 1998; 30: 337-48.
11. Bersohn MM. Sodium pump inhibition in sarcolemma from ischemic hearts. J. Mol. Cell. Cardiol. 1995; 27: 1483-9.
12. Murphy E, Perlman M, London RE, Steenbergen C. Amiloride delays the ischemia-induced rise in cytosolic free calcium. Circ. Res. 1991; 68: 1250-8.
13. Bell JR, Eaton P, Shattock MJ. Role of p38-mitogen-activated protein kinase in ischaemic preconditioning in rat heart. Clin. Exp. Pharmacol. Physiol. 2008; 35: 126-34.
14. Murphy E, Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol. Rev. 2008; 88: 581-609.
15. Lazdunski M, Frelin C, Vigne P. The sodium/hydrogen exchange system in cardiac cells. Its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH. J. Mol. Cell. Cardiol. 1985; 17: 1029-42.
16. Halestrap AP. Mitochondria and reperfusion injury of the heart: A holey death but not beyond salvation. J. Bioenerg. Biomembr. 2009; 41: 113-21.
17. Gustafsson AB, Gottlieb RA. Autophagy in ischemic heart disease. Circ. Res. 2009; 104: 150-8.
18. Anderson ME. Multiple downstream proarrhythmic targets for calmodulin kinase II. Moving beyond an ion channel-centric focus. Cardiovasc. Res. 2007; 73: 657-66.
19. Bers DM. Calcium cycling and signaling in cardiac myocytes. Annu. Rev. Physiol. 2008; 70: 23-49.
20. 2+/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart. Cardiovasc. Res. 2007; 73: 631-40.
21. Bartel S, Vetter D, Schlegel WP, Wallukat G, Krause EG, Karczewski P. Phosphorylation of phospholamban at threonine-17 in the absence and presence of β-adrenergic stimulation in neonatal rat cardiomyocytes. J. Mol. Cell. Cardiol. 2000; 32: 2173-85.
22. Said M, Mundiña-Weilenmann C, Vittone L, Mattiazzi A. The relative relevance of phosphorylation of the Thr(17) residue of phospholamban is different at different levels of β-adrenergic stimulation. Pflügers Arch. 2002; 444: 801-9.
23. C isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure. Circ. Res. 2003; 92: 912-19.
24. 2+/calmodulin-dependent protein kinase II induces hypertrophy and dilated cardiomyopathy associated with increased protein phosphatase 2A activity. J. Biol. Chem. 2002; 277: 1261-7.
25. Wu Y, Temple J, Zhang R et al. Calmodulin kinase II and arrhythmias in a mouse model of cardiac hypertrophy. Circulation 2002; 106: 1288-93.
26. Vittone L, Mundiña-Weilenmann C, Said M, Ferrero P, Mattiazzi A. Time course and mechanisms of phosphorylation of phospholamban residues in ischemia-reperfused rat hearts. Dissociation of phospholamban phosphorylation pathways. J. Mol. Cell. Cardiol. 2002; 34: 39-50.
27. Vila-Petroff M, Salas MA, Said M et al. CaMKII inhibition protects against necrosis and apoptosis in irreversible ischemia-reperfusion injury. Cardiovasc. Res. 2007; 73: 689-98.
28. 2+/calmodulin dependent protein kinase II inhibitor KN-93 reduces dopamine contents in PC12h cells. Biochem. Biophys. Res. Commun. 1991; 181: 968-75.
29. 2+/calmodulin-dependent protein kinase: A key component in the contractile recovery from acidosis. Cardiovasc. Res. 2007; 73: 648-56.
30. Salas MA, Valverde CA, Sánchez G et al. The signaling pathway of CaMKII-mediated apoptosis and necrosis in the ischemia/reperfusion injury. J. Mol. Cell. Cardiol. 2010; 48: 1298-306.
31. 2+/calmodulin-dependent protein kinase inhibition suppresses post-ischemic arrhythmogenesis and mediates sinus bradycardic recovery in reperfusion. Int. J. Cardiol. 2011; Epub 9 Mar 2011; doi: .
32. 2+/calmodulin-dependent protein kinase II. Am. J. Physiol. Heart Circ. Physiol. 2008; 295: H1669-83.
33. Xie LH, Chen F, Karagueuzian HS, Weiss JN. Oxidative-stress-induced afterdepolarizations and calmodulin kinase II signaling. Circ. Res. 2009; 104: 79-86.
34. δC is a common intermediate of diverse death stimuli-induced heart muscle cell apoptosis. J. Biol. Chem. 2007; 282: 10833-9.
35. 2+ overload causes mitochondrial-dependent apoptosis in ventricular myocytes. Circ. Res. 2005; 97: 1009-17.
36. Peng W, Zhang Y, Zheng M et al. Cardioprotection by CaMKII-δB is mediated by phosphorylation of heat shock factor 1 and subsequent expression of inducible heat shock protein 70. Circ. Res. 2010; 106: 102-10.
37. Leinwand LA. Sex is a potent modifier of the cardiovascular system. J. Clin. Invest. 2003; 112: 302-7.
38. Konhilas JP, Leinwand LA. The effects of biological sex and diet on the development of heart failure. Circulation 2007; 116: 2747-59.
39. Luczak ED, Leinwand LA. Sex-based cardiac physiology. Annu. Rev. Physiol. 2009; 71: 1-18.
40. 2+] in rat cardiac myocytes. Pflügers Arch. 2001; 441: 709-16.
41. Farrell SR, Ross JL, Howlett SE. Sex differences in mechanisms of cardiac excitation-contraction coupling in rat ventricular myocytes. Am. J. Physiol. Heart Circ. Physiol. 2010; 299: H36-45.
42. Howlett SE. Age-associated changes in excitation-contraction coupling are more prominent in ventricular myocytes from male rats than in myocytes from female rats. Am. J. Physiol. Heart Circ. Physiol. 2010; 298: H659-70.
43. i in female rat cardiac myocytes. Clin. Exp. Pharmacol. Physiol. 2003; 30: 489-94.
44. 2+ handling and contractile function. Physiol. Res. 2009; 58: 293-7.
45. Bell JR, Porrello ER, Huggins CE, Harrap SB, Delbridge LM. The intrinsic resistance of female hearts to an ischemic insult is abrogated in primary cardiac hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 2008; 294: H1514-22.
46. Brown DA, Lynch JM, Armstrong CJ et al. Susceptibility of the heart to ischaemia-reperfusion injury and exercise-induced cardioprotection are sex-dependent in the rat. J. Physiol. 2005; 564: 619-30.
47. Lagranha CJ, Deschamps A, Aponte A, Steenbergen C, Murphy E. Sex differences in the phosphorylation of mitochondrial proteins result in reduced production of reactive oxygen species and cardioprotection in females. Circ. Res. 2010; 106: 1681-91.
48. Zhai P, Eurell TE, Cotthaus R, Jeffery EH, Bahr JM, Gross DR. Effect of estrogen on global myocardial ischemia-reperfusion injury in female rats. Am. J. Physiol. Heart Circ. Physiol. 2000; 279: H2766-75.
49. Liu ML, Xu X, Rang WQ, Li YJ, Song HP. Influence of ovariectomy and 17β-estradiol treatment on insulin sensitivity, lipid metabolism and post-ischemic cardiac function. Int. J. Cardiol. 2004; 97: 485-93.
50. Kolodgie FD, Farb A, Litovsky SH et al. Myocardial protection of contractile function after global ischemia by physiologic estrogen replacement in the ovariectomised rat. J. Mol. Cell. Cardiol. 1997; 29: 2403-14.
51. Nikolic I, Liu D, Bell JA, Collins J, Steenbergen C, Murphy E. Treatment with an estrogen receptor-β-selective agonist is cardioprotective. J. Mol. Cell. Cardiol. 2007; 42: 769-80.
52. Delyani JA, Murohara T, Nossuli TO, Lefer AM. Protection from myocardial reperfusion injury by acute administration of 17β-estradiol. J. Mol. Cell. Cardiol. 1996; 28: 1001-8.
53. Zhai P, Eurell TE, Cooke PS, Lubahn DB, Gross DR. Myocardial ischemia-reperfusion injury in estrogen receptor-α knockout and wild-type mice. Am. J. Physiol. Heart Circ. Physiol. 2000; 278: H1640-7.
54. Wang M, Crisostomo P, Wairiuko GM, Meldrum DR. Estrogen receptor-α mediates acute myocardial protection in females. Am. J. Physiol. Heart Circ. Physiol. 2006; 290: H2204-9.
55. Wang M, Wang Y, Weil B et al. Estrogen receptor β mediates increased activation of PI3K/Akt signaling and improved myocardial function in female hearts following acute ischemia. Am. J. Physiol. Regul. Intergr. Comp. Physiol. 2009; 296: R972-8.
56. Gabel SA, Walker VR, London RE, Steenbergen C, Korach KS, Murphy E. Estrogen receptor β mediates gender differences in ischemia/reperfusion injury. J. Mol. Cell. Cardiol. 2005; 38: 289-97.
57. Booth EA, Obeid NR, Lucchesi BR. Activation of estrogen receptor-α protects the in vivo rabbit heart from ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 2005; 289: H2039-47.
58. Novotny JL, Simpson AM, Tomicek NJ, Lancaster TS, Korzick DH. Rapid estrogen receptor-α activation improves ischemic tolerance in aged female rats through a novel protein kinase Cε-dependent mechanism. Endocrinology 2009; 150: 889-96.
59. Liu GS, Cohen MV, Mochly-Rosen D, Downey JM. Protein kinase C-ε is responsible for the protection of preconditioning in rabbit cardiomyocytes. J. Mol. Cell. Cardiol. 1999; 31: 1937-48.
60. Baines CP, Song CX, Zheng YT et al. Protein kinase Cepsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ. Res. 2003; 92: 873-80.
61. Deschamps AM, Murphy E. Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats. Am. J. Physiol. Heart Circ. Physiol. 2009; 297: H1806-13.
62. Bopassa JC, Eghbali M, Toro L, Stefani E. A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 2010; 298: H16-23.
63. Murphy E, Steenbergen C. Cardioprotection in females: A role for nitric oxide and altered gene expression. Heart Fail. Rev. 2007; 12: 293-300.
64. Burley DS, Ferdinandy P, Baxter GF. Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion. Opportunities and obstacles for survival signaling. Br. J. Pharmacol. 2007; 152: 855-69.
65. Camper-Kirby D, Welch S, Walker A et al. Myocardial Akt activation and gender: Increased nuclear activity in females versus males. Circ. Res. 2001; 88: 1020-7.
66. Patten RD, Pourati I, Aronovitz MJ et al. 17β-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling. Circ. Res. 2004; 95: 692-9.
67. Ren J, Hintz KK, Roughead ZK et al. Impact of estrogen replacement on ventricular myocyte contractile function and protein kinase B/Akt activation. Am. J. Physiol. Heart Circ. Physiol. 2003; 284: H1800-7.
68. Sovershaev MA, Egorina EM, Andreasen TV, Jonassen AK, Ytrehus K. Preconditioning by 17β-estradiol in isolated rat heart depends on PI3-K/PKB pathway, PKC, and ROS. Am. J. Physiol. Heart Circ. Physiol. 2006; 291: H1554-62.
69. Urata Y, Ihara Y, Murata H et al. 17β-Estradiol protects against oxidative stress-induced cell death through the glutathione/glutaredoxin-dependent redox regulation of Akt in myocardiac H9c2 cells. J. Biol. Chem. 2006; 281: 13092-102.
70. Node K, Kitakaze M, Kosaka H, Minamino T, Funaya H, Hori M. Amelioration of ischemia- and reperfusion-induced myocardial injury by 17β-estradiol: Role of nitric oxide and calcium-activated potassium channels. Circulation 1997; 96: 1953-63.
71. 2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. J. Biol. Chem. 1993; 268: 26286-95.
72. 1 subunit and reduced ischemia/reperfusion injury. Circ. Res. 2006; 98: 403-11.
73. 2+/calmodulin-dependent protein kinase II. Br. J. Pharmacol. 2009; 157: 705-15.
74. Shinmura K, Nagai M, Tamaki K, Bolli R. Loss of ischaemic preconditioning in ovariectomised rat hearts: Possible involvement of impaired protein kinase C epsilon phosphorylation. Cardiovasc. Res. 2008; 79: 387-94.
75. McNulty PH, Jagasia D, Whiting JM, Caulin-Glaser T. Effect of 6-wk estrogen withdrawal or replacement on myocardial ischemic tolerance in rats. Am. J. Physiol. Heart Circ. Physiol. 2000; 278: H1030-4.
76. Bae S, Zhang L. Gender differences in cardioprotection against ischemia/reperfusion injury in adult rat hearts. Focus on Akt and protein kinase C signaling. J. Pharmacol. Exp. Ther. 2005; 315: 1125-35.
77. McCully JD, Toyoda Y, Wakiyama H, Rousou AJ, Parker RA, Levitsky S. Age- and gender-related differences in ischemia/reperfusion injury and cardioprotection: Effects of diazoxide. Ann. Thorac. Surg. 2006; 82: 117-23.
78. Willems L, Zatta A, Holmgren K, Ashton KJ, Headrick JP. Age-related changes in ischemic tolerance in male and female mouse hearts. J. Mol. Cell. Cardiol. 2005; 38: 245-56.
79. 2+ exchanger increases susceptibility to ischemia/reperfusion injury in male, but not female, transgenic mice. Circ. Res. 1998; 83: 1215-23.
80. 2+ loading and adrenergic stimulation reveal male/female differences in susceptibility to ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 2002; 283: H481-9.
81. Nam UH, Wang M, Crisostomo PR et al. The effect of chronic exogenous androgen on myocardial function following acute ischemia-reperfusion in hosts with different baseline levels of sex steroids. J. Surg. Res. 2007; 142: 113-18.
82. Callies F, Strömer H, Schwinger RH et al. Administration of testosterone is associated with a reduced susceptibility to myocardial ischemia. Endocrinology 2003; 144: 4478-83.
83. 1-adrenoceptor stimulation. Br. J. Pharmacol. 2008; 153: 693-709.
84. Liu J, Tsang S, Wong TM. Testosterone is required for delayed cardioprotection and enhanced heat shock protein 70 expression induced by preconditioning. Endocrinology 2006; 147: 4569-77.
85. 1-adrenoceptor stimulation are associated with increased activities of RyR, SERCA, and NCX in the heart. Am. J. Physiol. Cell Physiol. 2009; 296: C766-82.
86. 2-adrenergic receptor exhibit differences in ischemia/reperfusion injury: Role of nitric oxide. Cardiovasc. Res. 2002; 53: 662-71.